Joanne P. McLaughlin

Diversified prime and boost protocols using recombinant vaccinia virus and recombinant non-replicating avian pox virus to enhance T-cell immunity and antitumor responses

James W. Hodge, Joanne P. McLaughlin, Judith A. Kantor et al. · Vaccine · 1997 · 202 citations

Vaccination, Vaccine Development, Medicine +11

Admixture of a recombinant vaccinia virus containing the gene for the costimulatory molecule B7 and a recombinant vaccinia virus containing a tumor-associated antigen gene results in enhanced specific T-cell responses and antitumor immunity.

James W. Hodge, Joanne P. McLaughlin, Scott I. Abrams et al. · PubMed · 1995 · 92 citations

Adaptive Immune System, Immunology, Immunoediting +21

Improved immunotherapy of a recombinant carcinoembryonic antigen vaccinia vaccine when given in combination with interleukin-2.

Joanne P. McLaughlin, Jeffrey Schlom, Judy Kantor et al. · PubMed · 1996 · 66 citations

Immunology, Immune Regulation, Pathology +18

Therapeutic Antitumor Response After Immunization with an Admixture of Recombinant Vaccinia Viruses Expressing a Modified MUC1 Gene and the Murine T-Cell Costimulatory Molecule B7

Junji Akagi, James W. Hodge, Joanne P. McLaughlin et al. · Journal of Immunotherapy · 1997 · 66 citations

Immunology, Pathology, Immunotherapy +19

Immunization with a Syngeneic Tumor Infected with Recombinant Vaccinia Virus Expressing Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Induces Tumor Regression and Long-Lasting Systemic Immunity

Joanne P. McLaughlin, Scott I. Abrams, Judy Kantor et al. · Journal of Immunotherapy · 1997 · 37 citations